Abstract
Introduction
Rectal cancer patients frequently present with locally advanced disease for which the standard of care includes neoadjuvant chemoradiotherapy followed by total mesorectal excision. Positive lymph nodes are one of the most powerful risk factors for recurrence and survival in colorectal cancer. In the absence of specific rectal guidelines, the literature recommends to the pathologist to optimize the number of rectal lymph nodes (LN) retrieved. We made a literature review in order to identify factors that could potentially affect the number of LN retrieved in specimens of patients with rectal cancer treated by chemoradiotherapy (CRT) followed by total mesorectal excision (TME).
Results
Age did not have a significant effect on LN yield. The effect of sex on LN number is not consistent in the literature. Most of the papers did not find a relationship between lower LN obtained and gender. Laparoscopy for primary rectal cancer is associated with a greater number of LN as well as short-term benefits. Tumors in the upper rectum are associated with a higher number of LN than those in the mid and lower rectum. The type of surgery had no effect on lymph node yield either. Tumors with complete or almost complete pathologic regression were exactly the ones with lower number of lymph nodes detected. Approximately one-third of patients with neoadjuvant treatment had less than 12 LN yield.
Conclusion
The tumor regression grade is the most important factor for the decrease in the number of lymph nodes.
This is a preview of subscription content, log in via an institution to check access.
References
Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740
Miller ED, Robb BW, Cummings OW, Johnstone PA (2012 Sep) The effects of preoperative chemoradiotherapy on lymph node sampling in rectal cancer. Dis Colon rectum 55(9):1002–1007
Greene FL, Page DL, Fleming ID et al (2006) AJCC cancer staging manual. American Joint Committee, 6th edn. Springer, New York, NY, pp 127–138
Ahn YJ, Kwon HY, Park YA, Sohn SK, Lee KY (2013) Contributing factors on lymph node yield after surgery for mid-low rectal cancer. Yonsei Med J 54(2):389–395
Ha YH, Jeong SY, Lim SB et al (2010) Influence of preoperative hemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg 252:336–340
Amajoyi R, Lee Y, Recio PJ, Kondylis PD (2013) Neoadjuvant therapy for rectal cancer decreases the number of lymph nodes harvested in operative specimens. Am J Surg 205(3):289–292
Morcos B, Baker B, Al Masri M, Haddad H, Hashem S (2010) Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy. Eur J Surg Oncol 36:345–349
Lujan J, Valero G, Hernandez Q, Sanchez A, Frutos MD, Parrilla P (2009) Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg 96(9):982–989
Boutros M, Hippalgaonkar N, Silva E, Allende D, Wexner SD, Berho M (2013) Laparoscopic resection of rectal cancer results in higher lymph node yield and better short-term outcomes than open surgery: a large single-center comparative study. Dis Colon rectum 56(6):679–688
Damin DC, Rosito MA, Contu PC et al (2012) Lymph node retrieval after preoperative chemoradiotherapy for rectal cancer. J Gastrointest Surg 16(8):1573–1580
Berho M, Oviedo M, Stone E, Chen C, Nogueras J, Weiss E, Sands D, Wexner S (2009) The correlation between tumour regression grade and lymph node status after chemoradiation in rectal cancer. Color Dis 11(3):254–258
Marks JH, Valsdottir EB, Rather AA (2010) Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon rectum 53:1023–1029
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bustamante-Lopez, L., Nahas, C.S., Nahas, S.C. et al. Understanding the factors associated with reduction in the number of lymph nodes in rectal cancer patients treated by neoadjuvant treatment. Int J Colorectal Dis 32, 925–927 (2017). https://doi.org/10.1007/s00384-016-2747-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-016-2747-7